Restoring testosterone levels by adding dehydroepiandrosterone to a drospirenone containing combined oral contraceptive: I. Endocrine effects

被引:4
作者
Zimmerman, Y. [1 ]
Foidart, J. -M. [2 ]
Pintiaux, A. [2 ]
Minon, J. -M. [3 ]
Fauser, B. C. J. M. [4 ]
Cobey, K. [5 ]
Bennink, H. J. T. Coelingh [1 ]
机构
[1] Pantarhei Biosci, Zeist, Netherlands
[2] Univ Hosp, CHR Citadel, Dept Obstet Gynecol, Liege, Belgium
[3] Univ Hosp, CHR Citadel, Dept Lab Med, Liege, Belgium
[4] Univ Med Ctr Utrecht, Dept Reprod Med & Gynecol, Utrecht, Netherlands
[5] Univ Stirling, Sch Nat Sci, Dept Psychol, Stirling FK9 4LA, Scotland
关键词
Free testosterone; SHBG; DHEA; Androgens; NOMEGESTROL ACETATE; WOMEN; REPLACEMENT; 17-BETA-ESTRADIOL; ETHINYLESTRADIOL; PHARMACOKINETICS; LEVONORGESTREL; ANDROGENS; MEN;
D O I
10.1016/j.contraception.2014.11.002
中图分类号
R71 [妇产科学];
学科分类号
100211 ;
摘要
Objectives: Combined oral contraceptives (COCs) decrease testosterone (T) levels. This study investigated restoration of T and other androgen concentrations during COC use by 'co-administration' of dehydroepiandrosterone (DHEA). Study design: In this randomized, double-blind, placebo-controlled study in 99 new COC starters (18-35 years old with body mass index range 18-34 kg/m(2)), a COC containing 30 mcg ethinylestradiol (EE) and 3 mg drospirenone (DRSP) was used for 3 cycles, followed by 6 cycles of the same COC combined with either 50 mg/day DHEA or placebo. Total T, albumin, sex hormone-binding globulin (SHBG), DHEA-sulfate (DHEA-S), Delta 4-androstenedione (AD), 3 alpha-androstanediol glucuronide (ADG) and estradiol (E-2) were measured, whereas free T and the free T index (FTI) were calculated. Assessments took place at baseline (no COC use), after the run-in period (COC use alone) and during the treatment period (DHEA or placebo). Results: During COC use alone, androgen levels decreased, especially total T by 62% and free T by 86%, and SHBG increased by 243%. Total T increased with DHEA compared to placebo (change from end of run-in period to end of treatment period 1.3 +/- 1.2 nmol/L vs. 0.0 +/- 0.4 nmol/L; p<.0001)-and was restored to baseline levels. Free T and the FTI increased significantly (p<.0001), but the free T level was still 53% below baseline levels. DHEA-S, AD and ADG increased significantly to levels above baseline (p<.0001 for each). DHEA had no effect on SHBG, albumin and E-2. Conclusions: An EE/DRSP containing COC strongly suppressed endogenous androgen concentrations in all users. The addition of 50 mg DHEA to a COC regimen containing EE/DRSP restored total T to baseline levels, but free T levels were restored by only 47% as most of the T remains bound to SHBG. Implications: When using a COC that increases SHBG considerably, a daily dose of 50 mg DREA is insufficient to normalize free T levels completely. (C) 2015 Elsevier Inc. All rights reserved.
引用
收藏
页码:127 / 133
页数:7
相关论文
共 34 条
[1]   Effects of a monophasic combined oral contraceptive containing nomegestrol acetate and 17β-oestradiol in comparison to one containing levonorgestrel and ethinylestradiol on markers of endocrine function [J].
Agren, Ulla M. ;
Anttila, Marjatta ;
Maenpaa-Liukko, Kristiina ;
Rantala, Maija-Liisa ;
Rautiainen, Hilkka ;
Sommer, Werner F. ;
Mommers, Ellen .
EUROPEAN JOURNAL OF CONTRACEPTION AND REPRODUCTIVE HEALTH CARE, 2011, 16 (06) :458-467
[2]  
[Anonymous], 2005, Clinical Gynecologic Endocrinology and Infertility
[3]   Oral dehydroepiandrosterone for adrenal androgen replacement:: Pharmacokinetics and peripheral conversion to androgens and estrogens in young healthy females after dexamethasone suppression [J].
Arlt, W ;
Justl, HG ;
Callies, F ;
Reincke, M ;
Hübler, D ;
Oettel, M ;
Ernst, M ;
Schulte, HM ;
Allolio, B .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1998, 83 (06) :1928-1934
[4]   Female androgen insufficiency: the Princeton consensus statement on definition, classification, and assessment [J].
Bachmann, G ;
Bancroft, J ;
Braunstein, G ;
Burger, H ;
Davis, S ;
Dennerstein, L ;
Goldstein, I ;
Guay, A ;
Leiblum, S ;
Lobo, R ;
Notelovitz, M ;
Rosen, R ;
Sarrel, P ;
Sherwin, B ;
Simon, J ;
Simpson, E ;
Shifren, J ;
Spark, R ;
Traish, A .
FERTILITY AND STERILITY, 2002, 77 (04) :660-665
[5]  
Burger HG, 2002, FERTIL STERIL, V77, pS3
[6]   Diurnal rhythm and effects of oral contraceptives on serum dehydroepiandrosterone sulfate (DHEAS) are related to alterations in serum albumin rather than to changes in adrenocortical steroid secretion [J].
Carlström, K ;
Karlsson, R ;
Von Schoultz, B .
SCANDINAVIAN JOURNAL OF CLINICAL & LABORATORY INVESTIGATION, 2002, 62 (05) :361-368
[7]   Changes in androgens during treatment with four low-dose contraceptives [J].
Coenen, CMH ;
Thomas, CMG ;
Borm, GF ;
Hollanders, JMG ;
Rolland, R .
CONTRACEPTION, 1996, 53 (03) :171-176
[8]   Effects of a monophasic combined oral contraceptive containing nomegestrol acetate and 17β-oestradiol on ovarian function in comparison to a monophasic combined oral contraceptive containing drospirenone and ethinylestradiol [J].
Duijkers, Ingrid J. M. ;
Klipping, Christine ;
Grob, Paul ;
Korver, Tjeerd .
EUROPEAN JOURNAL OF CONTRACEPTION AND REPRODUCTIVE HEALTH CARE, 2010, 15 (05) :314-325
[9]   Oral contraceptive use changes brain activity and mood in women with previous negative affect on the pill-A double-blinded, placebo-controlled randomized trial of a levonorgestrel-containing combined oral contraceptive [J].
Gingnell, Malin ;
Engman, Jonas ;
Frick, Andreas ;
Moby, Lena ;
Wikstrom, Johan ;
Fredrikson, Mats ;
Sundstrom-Poromaa, Inger .
PSYCHONEUROENDOCRINOLOGY, 2013, 38 (07) :1133-1144
[10]   CHANGES IN UN-BOUND SEX STEROIDS AND SEX-HORMONE BINDING GLOBULIN BINDING-CAPACITY DURING ORAL AND VAGINAL PROGESTOGEN ADMINISTRATION [J].
GRANGER, LR ;
ROY, S ;
MISHELL, DR .
AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 1982, 144 (05) :578-584